title: Antibodies generated against Streptococci protect in a mouse model of disseminated aspergillosis.
abstract: Invasive aspergillosis (IA) resulting from infection by Aspergillus fumigatus is a leading cause of death in immunosuppressed populations. There are limited therapeutic options for this disease and currently no vaccine. There is evidence that some anti-A. fumigatus mAbs can provide protection against IA. However, vaccine development has been impeded by a paucity of immunological targets on this organism demonstrated to provide protective responses. Sialylated oligosaccharide epitopes found on a variety of pathogens, including fungi and group B streptococci (GBS), are thought to be major virulence factors of these organisms facilitating pathogen attachment to host cells and modulating complement activation and phagocytosis. Because some of these oligosaccharide structures are conserved across kingdoms, we screened a panel of mAbs raised against GBS serotypes for reactivity to A. fumigatus. This approach revealed that SMB19, a GBSIb type-specific mAb, reacts with A. fumigatus conidia and hyphae. The presence of this Ab in mice, as a result of passive or active immunization, or by enforced expression of the SMB19 H chain as a transgene, results in significant protection in both i.v. and airway-induced models of IA. This study demonstrates that some Abs generated against bacterial polysaccharides engage fungal pathogens and promote their clearance in vivo and thus provide rationale of alternative strategies for the development of vaccines or therapeutic mAbs against these organisms.
authors.affiliation: Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294; and Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294.
authors.forename: Rebekah E
authors.initials: RE
authors.lastname: Wharton
authors.affiliation: Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294; and.
authors.forename: Emily K
authors.initials: EK
authors.lastname: Stefanov
authors.affiliation: Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294; and.
authors.forename: R Glenn
authors.initials: RG
authors.lastname: King
authors.affiliation: Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294; and jfk@uab.edu.
authors.forename: John F
authors.initials: JF
authors.lastname: Kearney
mesh_terms: D000818:Animals; D000907:Antibodies, Bacterial / Q000008:administration & dosage / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000276:immunology*; D000918:Antibody Specificity / Q000276:immunology; D001228:Aspergillosis / Q000235:genetics / Q000276:immunology* / Q000401:mortality / Q000517:prevention & control*; D001230:Aspergillus / Q000276:immunology; D001921:Brain / Q000276:immunology / Q000473:pathology; D002118:Calcium / Q000378:metabolism; D004195:Disease Models, Animal; D007114:Immunization; D007668:Kidney / Q000276:immunology / Q000473:pathology; D051379:Mice; D008822:Mice, Transgenic; D020556:Neutrophil Infiltration / Q000276:immunology; D009844:Oligosaccharides / Q000378:metabolism; D011485:Protein Binding / Q000276:immunology; D013291:Streptococcus / Q000145:classification / Q000276:immunology*
chemical_list: D000907:Antibodies, Bacterial; D000911:Antibodies, Monoclonal; D009844:Oligosaccharides; D002118:Calcium
references.citation: Glycoconj J. 1999 Sep;16(9):545-54
references.pmid: 10815991
references.citation: J Immunol. 2009 Nov 15;183(10):6359-68
references.pmid: 19841173
references.citation: Eur J Immunol. 2003 May;33(5):1193-204
references.pmid: 12731044
references.citation: J Infect Dis. 2003 Jul 1;188(1):66-73
references.pmid: 12825173
references.citation: Eur J Immunol. 1981 Nov;11(11):877-83
references.pmid: 7035186
references.citation: PLoS Pathog. 2011 Nov;7(11):e1002372
references.pmid: 22102815
references.citation: J Immunol. 2012 Sep 1;189(5):2246-56
references.pmid: 22837487
references.citation: Antimicrob Agents Chemother. 2001 Dec;45(12):3474-81
references.pmid: 11709327
references.citation: Infect Immun. 1990 May;58(5):1476-8
references.pmid: 2323826
references.citation: Infect Immun. 1992 Apr;60(4):1598-602
references.pmid: 1548081
references.citation: Microbiol Rev. 1993 Jun;57(2):367-82
references.pmid: 8336672
references.citation: Infect Immun. 1994 Dec;62(12):5424-33
references.pmid: 7960122
references.citation: Int Immunol. 1997 Jan;9(1):27-41
references.pmid: 9043945
references.citation: Clin Diagn Lab Immunol. 2005 Sep;12(9):1063-8
references.pmid: 16148172
references.citation: J Immunol. 2006 Feb 1;176(3):1712-23
references.pmid: 16424201
references.citation: Nat Rev Microbiol. 2007 Jan;5(1):13-28
references.pmid: 17160002
references.citation: Infect Immun. 2007 Nov;75(11):5085-94
references.pmid: 17606600
references.citation: Infect Immun. 2007 Nov;75(11):5074-8
references.pmid: 17709417
references.citation: Vet Immunol Immunopathol. 2008 Sep 15;125(1-2):47-70
references.pmid: 18565595
references.citation: PLoS One. 2009;4(4):e5392
references.pmid: 19399183
references.citation: Eukaryot Cell. 2007 Nov;6(11):1953-63
references.pmid: 17890370